Frank D. Heuszel, the Chief Executive Officer of Impact Biomedical Inc. (NASDAQ:IBO), recently purchased 500 shares of the company's common…
Read More »Frank D. Heuszel, the Chief Executive Officer of Impact Biomedical Inc. (NASDAQ:IBO), recently purchased 500 shares of the company's common…
Read More »